BlossomHill Therapeutics, Inc.
AI summary Insiders and major institutional backers buy shares in BlossomHill Therapeutics' upsized $150 million initial public offering.
- Research score
- 63
- AI adjustment
- -11
Research score, not a recommendation.
Market data
Live quote and chart from Yahoo Finance, loaded through this server. Insider purchases are marked on the chart.
–
partial data Price history is incomplete; missing inputs count as neutral in the score.
Why this score
Research score: a weighted blend of the five factors, times the routine and offering discounts, minus the selling penalty.
Why are they buying?
AI · ipo_offering · catalyst credible · documentedThe purchases occurred concurrently with the closing of the company's initial public offering on August 10, 2026, where shares were priced at $16.00 following an upsized $150 million debut on Nasdaq.
Form 4 filings confirm that directors and officers, including representatives from major backers like OrbiMed and Cormorant, acquired shares directly as part of the initial public offering.
Stock Price & Insider Purchase History
Daily close price with open-market insider purchases plotted over time
Loading price history…
| Date | Insider | Role | Shares | Price | Value | Flags | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-10 | ORBIMED ADVISORS LLC history of ORBIMED ADVISORS LLC's purchases | Director | 625,000 | $16.00 | $10.0M | SEC filing for ORBIMED ADVISORS LLC (opens in a new tab) | |
| 2026-08-10 | GORDON CARL L history of GORDON CARL L's purchases | Director | 625,000 | $16.00 | $10.0M | SEC filing for GORDON CARL L (opens in a new tab) | |
| 2026-08-10 | Chen Bihua history of Chen Bihua's purchases | Director | 312,500 | $16.00 | $5.0M | SEC filing for Chen Bihua (opens in a new tab) | |
| 2026-08-10 | Schmid John P. history of Schmid John P.'s purchases | Director | 6,000 | $16.00 | $96.0K | SEC filing for Schmid John P. (opens in a new tab) | |
| 2026-08-07 → 2026-08-10 | Liptak Vincent Paul history of Liptak Vincent Paul's purchases | General counsel | 4,700 | $15.89 avg | $74.7K | ||
| 2026-08-07 | Liptak Vincent Paul | 2,500 | $15.80 | $39.5K | SEC filing for Liptak Vincent Paul (opens in a new tab) | ||
| 2026-08-10 | Liptak Vincent Paul | 2,200 | $16.00 | $35.2K | SEC filing for Liptak Vincent Paul (opens in a new tab) | ||
| 2026-08-10 | Keyes Jason A history of Keyes Jason A's purchases | CFO | 700 | $16.00 | $11.2K | SEC filing for Keyes Jason A (opens in a new tab) | |
| Total | $25.2M | ||||||
What happened next
A run ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
After this run became a cluster: 21 days +33.4%63 days –126 days –